MeSH D012223 - vasomotor rhinitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Padagis | Azelastine | Azelastine | 2014-05-08 | |||
| Azelastine, Fluticasone | Azelastine Fluticasone | 2021-02-18 | ||||
| Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan | 2014-07-15 | ||||
| Taro Pharmaceutical | Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan | 2017-02-27 | |||
| Mylan | Azelastine | Astelin | 1996-11-01 | |||
| Azelastine | Astepro | 2025-11-22 | 2008-10-15 | |||
| Azelastine, Fluticasone | Dymista | 2023-06-13 | 2012-05-01 | |||
| Azelastine | Optivar | 2000-05-22 | ||||
| Perrigo | Ibuprofen, Phenylephrine | Ibuprofen Phenylephrine | 2014-07-03 | |||
| GSK | Ibuprofen, Phenylephrine, Chlorpheniramine | Advil | 2011-12-21 | |||
| Lupin Research | Phenylephrine, Ketorolac tromethamine | Ketorolac Tromethamine Phenylephrine | 2019-07-01 |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
67%8/12
Approved: 7Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use